Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for XOMA Royalty Corporation (XOMA : NSDQ)
 
 • Company Description   
XOMA ROYALTY is a biotechnology royalty aggregator. The company acquires the potential future economics associated with pre-commercial therapeutic candidates which have been licensed to pharmaceutical or biotechnology companies. XOMA ROYALTY, formerly known as XOMA Corporation, is based in EMERYVILLE, Calif.

Number of Employees: 13

 
 • Price / Volume Information   
Yesterday's Closing Price: $25.20 Daily Weekly Monthly
20 Day Moving Average: 72,615 shares
Shares Outstanding: 11.97 (millions)
Market Capitalization: $301.57 (millions)
Beta: 0.93
52 Week High: $35.00
52 Week Low: $18.35
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 4.07% -0.44%
12 Week 31.05% 6.91%
Year To Date -4.11% -9.11%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2200 POWELL STREET SUITE 310
-
EMERYVILLE,CA 94608
USA
ph: 510-204-7200
fax: 510-649-7571
investorrelations@xoma.com http://www.xoma.com
 
 • General Corporate Information   
Officers
Owen Hughes - Chief Executive Officer and Director
Jack L. Wyszomierski - Chairman of the Board
Thomas Burns - Senior Vice President; Finance and Chief Financial
Heather L. Franklin - Director
Natasha Hernday - Director

Peer Information
XOMA Royalty Corporation (CORR.)
XOMA Royalty Corporation (RSPI)
XOMA Royalty Corporation (CGXP)
XOMA Royalty Corporation (BGEN)
XOMA Royalty Corporation (GTBP)
XOMA Royalty Corporation (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 98419J206
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/12/25
Share - Related Items
Shares Outstanding: 11.97
Most Recent Split Date: 10.00 (0.05:1)
Beta: 0.93
Market Capitalization: $301.57 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.12 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.02 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/12/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 1,080.00
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.56
Price/Cash Flow: -
Price / Sales: 7.03
EPS Growth
vs. Year Ago Period: 106.98%
vs. Previous Quarter: 113.04%
Sales Growth
vs. Year Ago Period: 967.92%
vs. Previous Quarter: 82.90%
ROE
06/30/25 - -
03/31/25 - -12.43
12/31/24 - -25.08
ROA
06/30/25 - -
03/31/25 - -4.85
12/31/24 - -9.64
Current Ratio
06/30/25 - -
03/31/25 - 5.54
12/31/24 - 5.15
Quick Ratio
06/30/25 - -
03/31/25 - 5.54
12/31/24 - 5.15
Operating Margin
06/30/25 - -
03/31/25 - -25.44
12/31/24 - -76.82
Net Margin
06/30/25 - -
03/31/25 - -13.04
12/31/24 - -58.15
Pre-Tax Margin
06/30/25 - -
03/31/25 - -19.85
12/31/24 - -68.38
Book Value
06/30/25 - -
03/31/25 - 7.08
12/31/24 - 6.95
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 1.18
12/31/24 - 1.31
Debt-to-Capital
06/30/25 - -
03/31/25 - 54.15
12/31/24 - 56.61
 

Powered by Zacks Investment Research ©